Digitalis Ventures — 2019 Investments
5 investments dated 2019 · listed companies and verified rows first · show all
Co-investorsNoro-Moseley PartnersSustainVC
Subscription e-commerce platform for pet owners in China.
Co-investorsCompanion FundDCM Ventures
Novel antibody-based therapeutics platform for animal health.
Co-investorsCambridge Innovation CapitalCompanion FundParkwalk Advisors
Scout Bio developed biotechnology therapies for pets, including a pipeline of monoclonal antibodies and gene therapy programs targeting chronic diseases in companion animals.
AgTechBiotechDeep TechHealthtechPhiladelphia, US
Mark Hefferman(Executive Officer, Director)
BoardAditya Kohli(Director)inTadataka Yamada(Director)Patrick Heron(Director)inCindy Cole(Director)inNancy Hong(Director)
Co-investorsCompanion FundCorrelation VenturesFrazier Life SciencesRiverVest Venture Partners
Terray is a drug discovery company that combines proprietary hardware, large-scale experimental datasets, and AI through its EMMI platform to design small molecule medicines.
AI & Machine LearningBiotechDeep Tech
Eli Berlin(Founder)in
BoardChris PicardoinDusan PerovicinSid ShenaiinSamuel BjorkinBassil Dahiyat, Ph.D.
Co-investorsDeviation CapitalMadrona Venture GroupSummit Peak InvestmentsKdT VenturesMana VenturesNVentures+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.